Source: FinanzNachrichten

Genentech: Genentech: FDA Accepts SBLA For Xolair To Treat Nasal Polyps

BASEL (dpa-AFX) - Genentech, a member of Swiss drug maker Roche Group (RHHBY), announced Wednesday that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics Lice...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Estimated Annual Revenue

Estimated Employees

Alexander Hardy's photo - CEO of Genentech

CEO

Alexander Hardy

CEO Approval Rating

61/100

Genentech is a biotechnology company that discovers, develops and commercializes medicines to treat patients with life-t... Read more